Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04486352
Title A Study of Targeted Agents With Atezolizumab for Patients With Recurrent or Persistent Endometrial Cancer (EndoMAP)
Recruitment Recruiting
Gender female
Phase Phase Ib/II
Variant Requirements No
Sponsors Alliance Foundation Trials, LLC.
Indications

endometrial carcinoma

Therapies

Atezolizumab + Talazoparib

Atezolizumab + Ipatasertib

Atezolizumab + Bevacizumab

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.